Regenxbio Other Liab from 2010 to 2024

RGNX Stock  USD 9.58  0.01  0.10%   
Regenxbio Other Liabilities yearly trend continues to be fairly stable with very little volatility. Other Liabilities will likely drop to about 58.5 M in 2024. During the period from 2010 to 2024, Regenxbio Other Liabilities regression line of annual values had r-squared of  0.49 and arithmetic mean of  39,862,270. View All Fundamentals
 
Other Liabilities  
First Reported
2015-06-30
Previous Quarter
111.7 M
Current Value
97.8 M
Quarterly Volatility
64.1 M
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 M, Interest Expense of 6.5 M or Selling General Administrative of 47.8 M, as well as many indicators such as Price To Sales Ratio of 8.26, Dividend Yield of 0.0 or PTB Ratio of 2.64. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Other Liab Growth Pattern

Below is the plot of the Other Liab of Regenxbio over the last few years. It is Regenxbio's Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Slightly volatile
   Other Liab   
       Timeline  

Regenxbio Other Liab Regression Statistics

Arithmetic Mean39,862,270
Geometric Mean3,495,672
Coefficient Of Variation152.72
Mean Deviation51,012,093
Median1,326,000
Standard Deviation60,877,697
Sample Variance3706.1T
Range178.6M
R-Value0.70
Mean Square Error2051.8T
R-Squared0.49
Significance0
Slope9,488,964
Total Sum of Squares51885.3T

Regenxbio Other Liab History

202458.5 M
2023112.5 M
202297.8 M
2021134.2 M
2020178.8 M
20195.2 M
20186.9 M

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Other Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Liabilities112.5 M58.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.